VN1R104P

Across TCGA pan-cancer cohorts, VN1R104P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated VN1R104P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher VN1R104P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VN1R104P expression acts as an unfavorable survival marker, although some lineages such as SKCM and HNSC show a favorable association.

THCA, OV, and DLBC are the cancer types where VN1R104P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.909	0.992	<.001	81	view →
OV	OS	Tertile	II,III,IV	0.626	0.850	<.001	54	view →
DLBC	OS	Tertile	III,IV	0.610	1.000	.004	48	view →
UCEC	OS	Tertile	IV	0.066	0.755	<.001	36	view →
READ	DFS	Tertile	All	0.112	0.845	.001	36	view →
SKCM	DFS	Tertile	All	0.827	0.209	.010	27	view →
KIRP	DFS	Tertile	All	0.183	0.613	.014	12	view →
LUAD	OS	Tertile	All	0.368	0.680	.033	9	view →
HNSC	OS	Tertile	II,III,IV	0.706	0.330	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

VN1R104P–THCA (OS)

Open the THCA breakdown →